US Stock MarketDetailed Quotes

CPIX Cumberland Pharmaceuticals

Watchlist
  • 2.270
  • -0.050-2.16%
Close Dec 20 16:00 ET
  • 2.230
  • -0.040-1.76%
Post 20:01 ET
31.88MMarket Cap-2.98P/E (TTM)

Cumberland Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-9.92%9.09M
-9.55%9.85M
-7.88%8.5M
-5.85%39.55M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
16.75%42.01M
9.66%9.12M
Operating revenue
-13.54%8.46M
-9.55%9.85M
-7.88%8.5M
-7.79%37.51M
16.84%9.11M
-14.25%9.79M
5.73%10.89M
-17.45%9.22M
16.08%40.68M
5.61%7.79M
Cost of revenue
-25.07%1.32M
12.50%1.71M
26.02%1.58M
-33.47%6.07M
-42.27%1.53M
-20.63%1.77M
-25.15%1.52M
-43.48%1.25M
3.49%9.12M
-20.30%2.65M
Gross profit
-6.70%7.76M
-13.13%8.14M
-13.19%6.92M
1.80%33.49M
20.85%7.82M
-9.45%8.32M
13.32%9.37M
-11.03%7.97M
21.04%32.89M
29.61%6.47M
Operating expense
-7.16%9.46M
-1.93%9.16M
-7.52%8.79M
11.51%43.04M
60.01%14M
7.49%10.19M
-7.60%9.35M
-7.30%9.51M
10.75%38.6M
-6.39%8.75M
Selling and administrative expenses
-0.20%7.07M
-0.52%7.01M
-3.75%6.52M
8.43%29.1M
19.04%8.2M
12.91%7.09M
4.16%7.04M
-2.03%6.78M
8.25%26.84M
2.51%6.89M
-Selling and marketing expense
-7.29%4.4M
-9.07%4.25M
-2.87%4.15M
10.75%18.45M
40.83%4.76M
15.39%4.74M
2.53%4.67M
-7.31%4.28M
10.96%16.66M
2.22%3.38M
-General and administrative expense
14.14%2.68M
16.34%2.76M
-5.25%2.37M
4.63%10.65M
-1.95%3.44M
8.21%2.34M
7.53%2.37M
8.54%2.5M
4.09%10.18M
2.79%3.51M
Research and development costs
-32.14%1.31M
-7.50%1.06M
-22.77%1.16M
-12.78%5.83M
-10.04%1.26M
12.28%1.92M
-37.21%1.15M
-14.07%1.5M
17.67%6.69M
-12.83%1.41M
Depreciation amortization depletion
-8.24%1.08M
-5.04%1.1M
-9.71%1.11M
59.90%8.1M
890.60%4.54M
-20.94%1.18M
-24.27%1.16M
-22.79%1.23M
15.92%5.07M
-54.95%458.22K
-Depreciation and amortization
-8.24%1.08M
-5.04%1.1M
-9.71%1.11M
59.90%8.1M
890.60%4.54M
-20.94%1.18M
-24.27%1.16M
-22.79%1.23M
15.92%5.07M
-54.95%458.22K
Operating profit
9.22%-1.69M
-4,591.40%-1.03M
-22.04%-1.87M
-67.48%-9.55M
-171.28%-6.18M
-546.81%-1.87M
101.24%22.86K
-18.55%-1.53M
25.69%-5.7M
47.68%-2.28M
Net non-operating interest income expense
-494.04%-68.18K
52.42%-64.51K
84.00%-21.78K
21.86%-381.01K
26.89%-97.79K
91.01%-11.48K
-10.62%-135.57K
-31.52%-136.16K
-577.68%-487.59K
-535.02%-133.76K
Non-operating interest income
-29.83%69.19K
8.38%61.84K
92.76%96.75K
191.50%286.85K
77.26%81K
356.45%98.6K
278.74%57.06K
212.89%50.19K
277.31%98.41K
585.10%45.7K
Non-operating interest expense
24.79%137.37K
-34.41%126.35K
-36.40%118.53K
13.97%667.86K
-0.37%178.79K
-26.29%110.08K
39.97%192.64K
55.85%186.35K
497.76%586K
547.06%179.46K
Other net income (expense)
-71.15%237.09K
497.17%3.65M
0
821.8K
60.60%981.81K
1.85M
-72.05%611.33K
0
Special income (charges)
-71.15%237.09K
----
----
34.43%821.8K
--0
--821.8K
----
----
--611.33K
--0
-Less:Other special charges
71.15%-237.09K
----
----
-34.43%-821.8K
--0
---821.8K
----
----
---611.33K
--0
Other non- operating income (expenses)
----
----
----
--2.83M
--0
----
--981.81K
--1.85M
----
----
Income before tax
-44.42%-1.53M
-225.56%-1.09M
-1,155.12%-1.89M
-12.61%-6.28M
-160.29%-6.28M
-153.71%-1.06M
164.01%869.09K
112.84%179.22K
-0.34%-5.58M
44.88%-2.41M
Income tax
64.92%11.44K
64.96%11.44K
64.92%11.44K
-33.52%45.77K
-48.17%24.96K
0.55%6.94K
0.54%6.94K
0.55%6.94K
97.33%68.85K
284.71%48.15K
Net income
-44.56%-1.54M
-227.89%-1.1M
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
-56.82%-5.65M
36.67%-2.46M
Net income continuous Operations
-44.56%-1.54M
-227.89%-1.1M
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
-0.95%-5.65M
43.94%-2.46M
Minority interest income
151.09%7.11K
-69.47%-17.03K
320.08%43.79K
35.53%-51.45K
60.07%-7.58K
4.57%-13.92K
65.41%-10.05K
-15.82%-19.9K
16.19%-79.8K
48.07%-18.99K
Net income attributable to the parent company
-47.15%-1.54M
-224.47%-1.09M
-1,112.71%-1.95M
-12.73%-6.28M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.2K
113.87%192.18K
-58.81%-5.57M
36.57%-2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-47.15%-1.54M
-224.47%-1.09M
-1,112.71%-1.95M
-12.73%-6.28M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.2K
113.87%192.18K
-58.81%-5.57M
36.57%-2.44M
Basic earnings per share
-57.14%-0.11
-233.33%-0.08
-1,500.00%-0.14
-15.79%-0.44
-158.82%-0.44
-133.33%-0.07
166.67%0.06
111.11%0.01
-58.33%-0.38
34.62%-0.17
Diluted earnings per share
-57.14%-0.11
-233.33%-0.08
-1,500.00%-0.14
-15.79%-0.44
-158.82%-0.44
-133.33%-0.07
166.67%0.06
111.11%0.01
-58.33%-0.38
34.62%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -9.92%9.09M-9.55%9.85M-7.88%8.5M-5.85%39.55M2.51%9.35M-11.63%10.09M5.73%10.89M-17.45%9.22M16.75%42.01M9.66%9.12M
Operating revenue -13.54%8.46M-9.55%9.85M-7.88%8.5M-7.79%37.51M16.84%9.11M-14.25%9.79M5.73%10.89M-17.45%9.22M16.08%40.68M5.61%7.79M
Cost of revenue -25.07%1.32M12.50%1.71M26.02%1.58M-33.47%6.07M-42.27%1.53M-20.63%1.77M-25.15%1.52M-43.48%1.25M3.49%9.12M-20.30%2.65M
Gross profit -6.70%7.76M-13.13%8.14M-13.19%6.92M1.80%33.49M20.85%7.82M-9.45%8.32M13.32%9.37M-11.03%7.97M21.04%32.89M29.61%6.47M
Operating expense -7.16%9.46M-1.93%9.16M-7.52%8.79M11.51%43.04M60.01%14M7.49%10.19M-7.60%9.35M-7.30%9.51M10.75%38.6M-6.39%8.75M
Selling and administrative expenses -0.20%7.07M-0.52%7.01M-3.75%6.52M8.43%29.1M19.04%8.2M12.91%7.09M4.16%7.04M-2.03%6.78M8.25%26.84M2.51%6.89M
-Selling and marketing expense -7.29%4.4M-9.07%4.25M-2.87%4.15M10.75%18.45M40.83%4.76M15.39%4.74M2.53%4.67M-7.31%4.28M10.96%16.66M2.22%3.38M
-General and administrative expense 14.14%2.68M16.34%2.76M-5.25%2.37M4.63%10.65M-1.95%3.44M8.21%2.34M7.53%2.37M8.54%2.5M4.09%10.18M2.79%3.51M
Research and development costs -32.14%1.31M-7.50%1.06M-22.77%1.16M-12.78%5.83M-10.04%1.26M12.28%1.92M-37.21%1.15M-14.07%1.5M17.67%6.69M-12.83%1.41M
Depreciation amortization depletion -8.24%1.08M-5.04%1.1M-9.71%1.11M59.90%8.1M890.60%4.54M-20.94%1.18M-24.27%1.16M-22.79%1.23M15.92%5.07M-54.95%458.22K
-Depreciation and amortization -8.24%1.08M-5.04%1.1M-9.71%1.11M59.90%8.1M890.60%4.54M-20.94%1.18M-24.27%1.16M-22.79%1.23M15.92%5.07M-54.95%458.22K
Operating profit 9.22%-1.69M-4,591.40%-1.03M-22.04%-1.87M-67.48%-9.55M-171.28%-6.18M-546.81%-1.87M101.24%22.86K-18.55%-1.53M25.69%-5.7M47.68%-2.28M
Net non-operating interest income expense -494.04%-68.18K52.42%-64.51K84.00%-21.78K21.86%-381.01K26.89%-97.79K91.01%-11.48K-10.62%-135.57K-31.52%-136.16K-577.68%-487.59K-535.02%-133.76K
Non-operating interest income -29.83%69.19K8.38%61.84K92.76%96.75K191.50%286.85K77.26%81K356.45%98.6K278.74%57.06K212.89%50.19K277.31%98.41K585.10%45.7K
Non-operating interest expense 24.79%137.37K-34.41%126.35K-36.40%118.53K13.97%667.86K-0.37%178.79K-26.29%110.08K39.97%192.64K55.85%186.35K497.76%586K547.06%179.46K
Other net income (expense) -71.15%237.09K497.17%3.65M0821.8K60.60%981.81K1.85M-72.05%611.33K0
Special income (charges) -71.15%237.09K--------34.43%821.8K--0--821.8K----------611.33K--0
-Less:Other special charges 71.15%-237.09K---------34.43%-821.8K--0---821.8K-----------611.33K--0
Other non- operating income (expenses) --------------2.83M--0------981.81K--1.85M--------
Income before tax -44.42%-1.53M-225.56%-1.09M-1,155.12%-1.89M-12.61%-6.28M-160.29%-6.28M-153.71%-1.06M164.01%869.09K112.84%179.22K-0.34%-5.58M44.88%-2.41M
Income tax 64.92%11.44K64.96%11.44K64.92%11.44K-33.52%45.77K-48.17%24.96K0.55%6.94K0.54%6.94K0.55%6.94K97.33%68.85K284.71%48.15K
Net income -44.56%-1.54M-227.89%-1.1M-1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K-56.82%-5.65M36.67%-2.46M
Net income continuous Operations -44.56%-1.54M-227.89%-1.1M-1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K-0.95%-5.65M43.94%-2.46M
Minority interest income 151.09%7.11K-69.47%-17.03K320.08%43.79K35.53%-51.45K60.07%-7.58K4.57%-13.92K65.41%-10.05K-15.82%-19.9K16.19%-79.8K48.07%-18.99K
Net income attributable to the parent company -47.15%-1.54M-224.47%-1.09M-1,112.71%-1.95M-12.73%-6.28M-157.89%-6.29M-156.78%-1.05M165.30%872.2K113.87%192.18K-58.81%-5.57M36.57%-2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -47.15%-1.54M-224.47%-1.09M-1,112.71%-1.95M-12.73%-6.28M-157.89%-6.29M-156.78%-1.05M165.30%872.2K113.87%192.18K-58.81%-5.57M36.57%-2.44M
Basic earnings per share -57.14%-0.11-233.33%-0.08-1,500.00%-0.14-15.79%-0.44-158.82%-0.44-133.33%-0.07166.67%0.06111.11%0.01-58.33%-0.3834.62%-0.17
Diluted earnings per share -57.14%-0.11-233.33%-0.08-1,500.00%-0.14-15.79%-0.44-158.82%-0.44-133.33%-0.07166.67%0.06111.11%0.01-58.33%-0.3834.62%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.